Skip to main content

Table 1 Clinical and virological follow-up at t1 (n = 48 patients) and t2 (n = 47 patients)

From: Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique

  t1 t2
CD4 count (cells/μl)a 234 (113–322) 236 (136–386)
HIV RNA (log10 copies/ml)a 3.8 (3.5–4) 3.9 (3,5–4.5)
Hb (g/dL)a 12.6 (11.3–13.1) 12.1 (11.2–13.3)
BMI (Kg/m2)a 22.2 (20.7–25.3) 21.9 (20.5–24.7)
Adherence (%)a 100 (92–100) 100 (92–100)
Percent of patients with <95% adherence to pharmacy appointments 41.7 41.3
  1. BMI Body mass index
  2. amedian (IQR)